Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer75

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer35

Views

Views
February 20252
March 202515
April 20253
May 20252
June 20253
July 202510
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Singapore13
Brazil3
Colombia1
Spain1
United Kingdom1
Hong Kong1
 

Top cities views

Views
Brasília1
Cachoeirinha1
Council Bluffs1
Erie1
Fortaleza1
Hong Kong1
Portland1
San Antonio1
Santiago de Cali1
Wallingford1